XML 116 R97.htm IDEA: XBRL DOCUMENT
v3.22.4

Summary of Significant Accounting Policies (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2022
Accounting Policies [Abstract] |
Schedule of cash and cash equivalents | The following represents a reconciliation of cash and cash equivalents in the condensed consolidated balance sheets to total cash, cash equivalents and restricted cash in the condensed consolidated statements of cash flows as of September 30, 2022 and December 31, 2021 (in thousands).
| As of
| September 30, 2022 |  | December 31, 2021
Cash and cash equivalents | $ | 50,370 |  |  | $ | 128,318 |
Restricted cash (presented within Other current assets) | 664 |  |  | 414 |
Cash, cash equivalents and restricted cash | $ | 51,034 |  |  | $ | 128,732 |
The following represents a reconciliation of cash and cash equivalents in the consolidated balance sheets to total cash, cash equivalents and restricted cash in the consolidated statement of cash flows as of December 31, 2021 and December 31, 2020.
| Year Ended December 31,
| 2021 |  | 2020
Cash and cash equivalents | $ | 128,318 |  |  | $ | 60,495 |
Restricted cash (presented within Other current assets) | 414 |  |  | 414 |
Cash, cash equivalents and restricted cash | $ | 128,732 |  |  | $ | 60,909 |
Customer concentration risk | Customers representing 10% or greater of revenue were as follows for the nine months ended September 30, 2022 and 2021:
| Nine months ended September 30,
| 2022 |  | 2021
Customer A | 24 | % |  | 16 | %
Customer B | 10 | % |  | — | %
Customer C | 10 | % |  | 3 | %
Customer D | 8 | % |  | 34 | %
Customer E | 8 | % |  | 12 | %
Customers representing 10% or greater of revenue were as follows for the years ended December 31, 2021 and 2020:
| Year Ended December 31,
| 2021 |  | 2020
| as Restated |  | as Restated
Customer A | 27 | % |  | 28 | %
Customer B | 15 | % |  | 27 | %
Customer C | 12 | % |  | 22 | %
Schedule of error corrections | The effects of the correction of these errors on the relevant financial statement line items is as follows:
| Year Ended December 31, 2021
| As Previously Reported |  | Adjustments |  | as Restated
Consolidated Balance Sheet |  |  |  |  |
Equity method investments | 26,479 |  |  | (1,727) |  |  | 24,752 |
Total assets | $ | 194,738 |  |  | $ | (1,727) |  |  | $ | 193,011 |
Accumulated deficit | (378,162) |  |  | (1,727) |  |  | (379,889) |
Total shareholders’ deficit | $ | (353,190) |  |  | $ | (1,727) |  |  | $ | (354,917) |
Total liabilities, contingently redeemable preferred equity, and shareholders' deficit | $ | 194,738 |  |  | $ | (1,727) |  |  | $ | 193,011 |
| Year Ended December 31, 2020
| As Previously Reported |  | Adjustments |  | as Restated
Consolidated Balance Sheet |  |  |  |  |
Contract assets | 6,064 |  |  | 122 |  |  | 6,186 |
Total current assets | 76,467 |  |  | 122 |  |  | 76,589 |
Equity method investments | 24,023 |  |  | (806) |  |  | 23,217 |
Total assets | $ | 119,664 |  |  | $ | (684) |  |  | $ | 118,980 |
Other accrued liabilities | 2,775 |  |  | 122 |  |  | 2,897 |
Total current liabilities | $ | 15,082 |  |  | $ | 122 |  |  | $ | 15,204 |
Total liabilities | $ | 35,666 |  |  | $ | 122 |  |  | $ | 35,788 |
Accumulated deficit | (332,394) |  |  | (806) |  |  | (333,200) |
Total shareholders’ deficit | $ | (310,410) |  |  | $ | (806) |  |  | $ | (311,216) |
Total liabilities, contingently redeemable preferred equity, and shareholders' deficit | $ | 119,664 |  |  | $ | (684) |  |  | $ | 118,980 |
| Year Ended December 31, 2021
| As Previously Reported |  | Adjustments |  | as Restated
Consolidated Statement of Operations and Comprehensive Loss |  |  |  |  |
Revenue from contracts with customers | 18,993 |  |  | (122) |  |  | 18,871 |
Revenue from related party transactions | 3,915 |  |  | (662) |  |  | 3,253 |
Total revenue | $ | 26,245 |  |  | $ | (784) |  |  | $ | 25,461 |
Cost of revenue from contracts with customers (exclusive of depreciation shown below) | (13,289) |  |  | 122 |  |  | (13,167) |
Total cost and operating expenses | $ | (76,602) |  |  | $ | 122 |  |  | $ | (76,480) |
Loss from operations | $ | (50,357) |  |  | $ | (662) |  |  | $ | (51,019) |
Loss before income taxes | $ | (47,972) |  |  | $ | (662) |  |  | $ | (48,634) |
Gain from equity method investees, net | 2,204 |  |  | (259) |  |  | 1,945 |
Net loss | $ | (45,768) |  |  | $ | (921) |  |  | $ | (46,689) |
Net loss allocated to common shareholders | $ | (82,526) |  |  | $ | (921) |  |  | $ | (83,447) |
Comprehensive loss | $ | (45,673) |  |  | $ | (921) |  |  | $ | (46,594) |
Net loss per share - basic and diluted | $ | (42.12) |  |  | $ | (0.47) |  |  | $ | (42.59) |
| Year Ended December 31, 2020
| As Previously Reported |  | Adjustments |  | as Restated
Consolidated Statement of Operations and Comprehensive Loss |  |  |  |  |
Revenue from contracts with customers | 12,865 |  |  | 122 |  |  | 12,987 |
Revenue from related party transactions | 4,752 |  |  | (549) |  |  | 4,203 |
Total revenue | $ | 18,780 |  |  | $ | (427) |  |  | $ | 18,353 |
Cost of revenue from contracts with customers (exclusive of depreciation shown below) | (8,063) |  |  | (122) |  |  | (8,185) |
Total cost and operating expenses | $ | (57,932) |  |  | $ | (122) |  |  | $ | (58,054) |
Loss from operations | $ | (39,152) |  |  | $ | (549) |  |  | $ | (39,701) |
Loss before income taxes | $ | (39,331) |  |  | $ | (549) |  |  | $ | (39,880) |
Gain from equity method investees, net | 2,424 |  |  | (257) |  |  | 2,167 |
Net loss | $ | (36,907) |  |  | $ | (806) |  |  | $ | (37,713) |
Net loss allocated to common shareholders | $ | (68,198) |  |  | $ | (806) |  |  | $ | (69,004) |
Comprehensive loss | $ | (36,282) |  |  | $ | (806) |  |  | $ | (37,088) |
Net loss per share - basic and diluted | $ | (41.84) |  |  | $ | (0.50) |  |  | $ | (42.34) |
| Year Ended December 31, 2021
| As Previously Reported |  | Adjustments |  | as Restated
Consolidated Statement of Changes in Redeemable Convertible Preferred Stock and Shareholders’ Equity (Deficit) |  |  |  |  |
Accumulated deficit - Balance at December 31, 2020 | $ | (332,394) |  |  | $ | (806) |  |  | $ | (333,200) |
Total shareholders’ deficit – balance at December 31, 2020 | $ | (310,410) |  |  | $ | (806) |  |  | $ | (311,216) |
Net loss | (45,768) |  |  | (921) |  |  | (46,689) |
Accumulated deficit - balance at December 31, 2021 | (378,162) |  |  | (1,727) |  |  | (379,889) |
Total shareholders’ deficit – balance at December 31, 2021 | $ | (353,190) |  |  | $ | (1,727) |  |  | $ | (354,917) |
| Year ended December 31, 2020
| As Previously Reported |  | Adjustments |  | as Restated
Consolidated Statement of Changes in Redeemable Convertible Preferred Stock and Shareholders’ Equity (Deficit) |  |  |  |  |
Accumulated deficit - Balance at December 31, 2019 | $ | (295,487) |  |  | $ | — |  |  | $ | (295,487) |
Total shareholders’ deficit – balance at December 31, 2019 | $ | (276,592) |  |  | $ | — |  |  | $ | (276,592) |
Net loss | (36,907) |  |  | (806) |  |  | (37,713) |
Accumulated deficit - balance at December 31, 2020 | (332,394) |  |  | (806) |  |  | (333,200) |
Total shareholders’ deficit – balance at December 31, 2020 | $ | (310,410) |  |  | $ | (806) |  |  | $ | (311,216) |
| Year Ended December 31, 2021
| As Previously Reported |  | Adjustments |  | as Restated
Consolidated Statement of Cash Flows |  |  |  |  |
Net loss | $ | (45,768) |  |  | $ | (921) |  |  | $ | (46,689) |
Adjustments to reconcile net loss to net cash used in operating activities: |  |  |  |  |
Non-cash recognition of licensing revenue | (2,684) |  |  | 662 |  |  | $ | (2,022) |
Gain from equity method investees, net | (2,204) |  |  | 259 |  |  | $ | (1,945) |
Changes in operating assets and liabilities: |  |  |  |  |
Contract assets | (5,636) |  |  | 122 |  |  | (5,514) |
Accounts payable and accrued salaries and wages | 1,378 |  |  | (122) |  |  | 1,256 |
Net cash used in operating activities | $ | (42,591) |  |  | $ | — |  |  | $ | (42,591) |
| Year Ended December 31, 2020
| As Previously Reported |  | Adjustments |  | as Restated
Consolidated Statement of Cash Flows |  |  |  |  |
Net loss | $ | (36,907) |  |  | $ | (806) |  |  | $ | (37,713) |
Adjustments to reconcile net loss to net cash used in operating activities: |  |  |  |  |
Non-cash recognition of licensing revenue | (1,567) |  |  | 549 |  |  | $ | (1,018) |
Gain from equity method investees, net | (2,424) |  |  | 257 |  |  | $ | (2,167) |
Changes in operating assets and liabilities: |  |  |  |  |
Contract assets | (5,483) |  |  | (122) |  |  | (5,605) |
Accounts payable and accrued salaries and wages | 568 |  |  | 122 |  |  | 690 |
Net cash used in operating activities | $ | (39,271) |  |  | $ | — |  |  | $ | (39,271) |
| Year Ended December 31, 2021
| As Previously Reported |  | as Restated
Gain on dilution | $ | 181 |  |  | $ | 503 |

X
- References No definition available. + Details
Name: | us-gaap_AccountingPoliciesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the components of cash and cash equivalents. + References No definition available. + Details
Name: | us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 9 -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 7 -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 8 -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794 + Details
Name: | us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 21 -URI https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 20 -URI https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 20 -URI https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 16 -URI https://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 18 -URI https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592 Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 21 -URI https://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592 + Details
Name: | us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration